Wegovy, the brand name for semaglutide at the 2.4 mg dose for weight loss, represents the first generation of GLP-1 obesity drugs. Approved by the FDA in 2021, Wegovy proved that a weekly injectable could produce meaningful weight loss at scale \u2014 14.9% average in the STEP-1 trial. Retatrutide, still in Phase 3 trials, represents the next generation. The difference is not just in the numbers but in the mechanism: Wegovy activates one receptor, retatrutide activates three. This comparison puts both drugs side by side to help you understand where each stands.<\/p>\n
Wegovy’s sole mechanism is GLP-1 receptor activation. It reduces appetite by slowing gastric emptying and acting on hunger centers in the brain. Retatrutide does everything Wegovy does through its GLP-1 component, plus adds GIP receptor activation for improved insulin sensitivity and glucagon receptor activation for increased energy expenditure. The result, based on the TRIUMPH-1 data announced in May 2026, is 28.3% weight loss at 80 weeks compared to Wegovy’s 14.9% at 68 weeks. The absolute difference: a 250-pound person loses roughly 37 pounds on Wegovy and roughly 70 pounds on retatrutide.<\/p>\n
Both drugs share the GLP-1 class side effect profile. Nausea is the most common \u2014 35-45% for Wegovy, 30-40% for retatrutide in their respective trials. The lower nausea rate for retatrutide despite higher efficacy reflects the triple-agonist design: the GLP-1 component does not need to be pushed as hard because the GIP and glucagon receptors carry part of the therapeutic burden. Wegovy does not cause the heart rate increase seen with retatrutide, which is specific to glucagon receptor activation.<\/p>\n
Wegovy is FDA approved, available by prescription in the United States, and covered by many insurance plans. The list price is approximately $1,350 per month, though most patients with insurance pay significantly less. Retatrutide is not FDA approved as of May 2026 and is only available through clinical trials or grey market research vendors. Grey market retatrutide costs $60 to $120 per 10 mg vial, but carries no quality guarantees. The choice between the two is not just about efficacy \u2014 it is about whether you value FDA approval and manufacturing quality over higher potential weight loss.<\/p>\n","protected":false},"excerpt":{"rendered":"
Wegovy vs Retatrutide: A Tale of Two Generations Wegovy, the brand name for semaglutide at the 2.4 mg dose for weight loss, represents the first generation of GLP-1 obesity drugs. Approved by the FDA in 2021, Wegovy proved that a weekly injectable could produce meaningful weight loss at scale \u2014 14.9% average in the STEP-1 […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-50","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=\/wp\/v2\/posts\/50","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=50"}],"version-history":[{"count":0,"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=\/wp\/v2\/posts\/50\/revisions"}],"wp:attachment":[{"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=50"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=50"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/retatrutidebuy.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=50"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}